DSI’s recent acquisition by Paris-based Product Life Group (PLG) has granted the company options to further expand into the European market. We hold prior experience in Europe and ROW and are excited to explore more opportunities in these regions. The addition of PLG’s resources and support will allow the DS InPharmatics team to dive even further into these regions and begin to bring our expertise worldwide.
We will be virtually attending the BIO Europe conference on October 24 through October 26.
About DSI
DSI is a full-service regulatory drug development consulting firm for pharmaceuticals, biologics and new drug and delivery platforms. DSI provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and next generation therapy products.
Since 2007, DSI have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.
Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represents the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.
Connect with DSI on LinkedIn or visit www.dsinpharmatics.com for more information.
Contact
Meranda Parascandola
Head of Business Development and Marketing
Mparascandola@dsinpharmatics.com
Design Space InPharmatics, llc. (DSI)
Tel: (855) 805-8402×104
